Market Tracker

07/07 9:03am ET

Heron Therapeutics Inc (NASDAQ:HRTX)

29.34
Delayed Data
As of Jul 06
 -0.86 / -2.85%
Today’s Change
6.51
Today|||52-Week Range
34.03
+191.65%
Year-to-Date

Today’s Trading

Previous close30.20
Today’s open29.75
Day’s range28.83 - 30.28
Volume672,430
Average volume (3 months)1,414,699
Market cap$1.1B
Dividend yield--
Data as of 07/06/2015

Growth & Valuation

Earnings growth (last year)+16.08%
Earnings growth (this year)+0.81%
Earnings growth (next 5 years)+44.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book14.00

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc+1.55+4.39%
ARNAArena Pharmaceutical...+0.08+1.80%
ITCIIntra-Cellular Thera...+3.03+9.73%
ACHNAchillion Pharmaceut...+0.12+1.40%
Data as of 07/06/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)-$0.70
Annual revenue (last year)$0.00
Annual profit (last year)-$76.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
Redwood City, California

Forecasts